Rockville's Vigene Biosciences closes $292M deal to be acquired

The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 29, 2021 Category: Pharmaceuticals Authors: Drew Hansen Source Type: news